Philip Morris International (PM) Morgan Stanley Global Consumer & Retail Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley Global Consumer & Retail Conference 2025 summary
9 Jul, 2026Strategic overview and market trends
Smoke-free products now represent over 40% of sales and are available in 100+ markets, with multiple product platforms in 30+ markets.
All three platforms—heat-not-burn, pouches, and e-vapor—are seen as essential to meet diverse smoker needs and drive conversion from cigarettes.
Smoke-free product growth is expected to be around 10-12%, outpacing the industry average and offsetting cigarette volume declines for five consecutive years.
Major untapped markets like India, Vietnam, and Turkey present significant future growth opportunities.
Regulatory environments are evolving, with more mature conversations around nicotine and harm reduction supporting category growth.
ZYN and U.S. pouch category performance
ZYN experienced supply constraints in Q4 but ramped up capacity faster than expected, leading to accelerated volume growth in Q3.
Marketing and promotional efforts in Q3 drove a sharp increase in brand equity and consumer engagement.
ZYN commands a premium price and captures over 50% of category growth, despite a price gap with competitors.
FDA decisions on pending PMTAs are expected to further support portfolio expansion and growth in 2024-2026.
The U.S. pouch category is the fastest-growing tobacco segment, with robust outlook through 2026.
International IQOS and regulatory landscape
IQOS continues double-digit growth, holding share despite regulatory headwinds like flavor bans and tax equalization in key markets such as Japan and Poland.
Japan is approaching a 50/50 split between combustibles and smoke-free products, with staged tax increases planned through 2029.
Regulatory and tax changes may cause short-term slowdowns but do not alter the long-term growth trajectory.
Innovation remains a key driver, with new IQOS versions and improved user experiences planned.
Expansion into new geographies and continued product innovation are expected to sustain growth.
Latest events from Philip Morris International
- 2025 EPS guidance targets 13–15% growth, led by robust smoke-free product expansion and margin gains.PM
Barclays 18th Annual Global Consumer Staples Conference 202516 Jul 2026 - Raised 2024 guidance after record H1 growth, led by IQOS and ZYN, with margin expansion.PM
Q2 20248 Jul 2026 - Smoke-free product momentum and multi-category strategy drive robust 2025 financial outlook.PM
2025 dbAccess Global Consumer Conference29 Jun 2026 - Smoke-free product momentum and raised EPS guidance highlight strong 2024 growth outlook.PM
21st Annual dbAccess Global Consumer Conference29 Jun 2026 - Smoke-free products drive growth, with ZYN ULTRA and IQOS expanding amid regulatory progress.PM
23rd annual dbAccess Global Consumer Conference2 Jun 2026 - Strong financial and smoke-free growth, dividend increase, and all board proposals but one approved.PM
AGM 20268 May 2026 - Adjusted EPS up 16% to $1.96, with smoke-free products now 43% of revenue, led by IQOS.PM
Q1 202624 Apr 2026 - Smoke-free growth and double-digit EPS gains fuel a strong 2026 outlook and new segment structure.PM
Q4 202521 Apr 2026 - Proxy materials corrected to confirm Werner Geissler as Compensation Committee Chair.PM
Proxy filing31 Mar 2026